CGL
ALXN

Clarius Group LLC’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Clarius Group LLC’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,353
Closed -$249K – 448
2021
Q2 		$249K Buy
1,353
+34
+3% +$6.26K 0.02% 350
2021
Q1 		$202K Buy
+1,319
New +$202K 0.02% 366